TSX:ONC - Post Discussion
Post by
canadafan on Nov 11, 2024 3:57pm
Shorting analysis, risk
Obviously, a few on here are shorting.
Looking at the upside.
They have fast track approval for both MBc & pancreatic cancer.
A $5 million grant to add an additional arm, from PanCan & now administered by CGAR. These are global experts in pancreatic cancer. Giving not only guidance, but cash support for future endeavours.
They will be overseeing the implementation of the upcoming " registration enabling" trial.
That is the one, they announced possible accelerated approval. And they are being able to utilize existing previous Trial results as the comparable. That reduces the cost, time & if determined, they can advance to licensing.
They clearly need financial support to progress with the panc trial. When that gets announced the price upside is multiples of existing.
and
will come with a trading hault.
meaning anyone shorting won't have time to cover
inlook forward to that day.
FYI, the upside could be much higher than you could ever imagine,
The present calc is roughly $12/billion.
That is more than 6x existing.
The downside?
it will never be zero. For argument sake use that number.
so give or take $1.
imho that risk ratio is insane.
You have been warned.
Be the first to comment on this post